期刊文献+

预防为主,规范诊疗,安全达标的糖尿病防治理念——解析2007年版《中国2型糖尿病防治指南》 被引量:3

Concept of prevention-based control, standardized diagnosis and treatment, target obtained safely in diabetes care:Comment on China Guideline for Type 2 Diabetes (2007 Edition)
原文传递
导出
摘要 中国的2型糖尿病患病率和糖尿病患者人数正在快速增长。为了更好地适应我国糖尿病防治工作的需要,符合和适应当今糖尿病防治认识进展水平,中华医学会糖尿病学分会组织专家编写出版了2007年版《中国2型糖尿病防治指南》。该指南以循证医学为基础,借鉴国际指南的优点,并结合中国的糖尿病实践,突出预防为主的方针,强调糖尿病的诊疗管理及多种心血管危险因素的综合防治,制定了更为严格的血糖控制目标,强调早期达标、安全降糖的重要性,并绘制出符合中国2型糖尿病发病特点的治疗流程。新指南的推广应用将会进一步提高我国的糖尿病防治水平。 The patients of type 2 diabetes mellitus are increasing in China. In order to meet the need of diabetes care and in accordance with the increasing recognition of diabetes care nowdays, " China Guideline for Type 2 Diabetes" (2007 Edition)is prepared by diabetic experts group organized by the Chinese Diabetes Society on the basis of new evidence related to prevention of both diabetes and its complications, the update guideline of many international organizations, as well as the clinical practice in China. The importance of not only diabetes prevention and management but also multifactorial intervention of cardiovascular risk factors are emphasized. More strict targets of glycemic control are recommended, underlining the importance of early target-reached and safe antihyperglycemia. However, the strategy of glycemic control should be based on pathophysiological features of Chinese diabetic population. The new guideline will improve the process of diabetes care.
出处 《国际内分泌代谢杂志》 2009年第2期73-76,87,共5页 International Journal of Endocrinology and Metabolism
关键词 2型糖尿病 指南 解析 Type 2 diabetes mellitus Guideline Comment
  • 相关文献

参考文献18

二级参考文献99

  • 1Erol Cerasi.胰岛素生成,胰岛素分泌及2型糖尿病:问题的核心在于β细胞(英文)[J].中华内分泌代谢杂志,2005,21(3):194-198. 被引量:86
  • 2International Diabetes Federation. Diabetes Arias, Second edition. 2003.
  • 3International Diabetes Federation. Diabetes Arias, Third edition. 2007.
  • 4中华人民共和国卫生部.2007中国卫生统计纪要.
  • 5Nathan DM, Cleary PA, Backlund JY, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med, 2005,353:2643-2653.
  • 6Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes ( UKPDS 35 ) : prospective observational study. BMJ, 2000,321:405- 412.
  • 7Gaede P, Vedel P, Larsen N, et al. Muhifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med, 2003,348:383-393.
  • 8Amemiya S, Kato K, Asayama K. The improved response in endogenous insulin due to continuous subcutaneous infusion of insulin therapy in juvenile diabetes. Tohoku J Exp Med, 1983,141 (Suppl) :713-717.
  • 9Garvey WT, Olefsky JM, Griffin J, et al. The effect of insulin treatment on insulin secretion and insulin action in type Ⅱ diabetes mellitus. Diabetes, 1985,34:222-234.
  • 10Glaser B, Leibovich G, Nesher R, et al. Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes. Acta Endocrinol, 1988,118:365-373.

共引文献798

同被引文献28

  • 1窦毓,刘乃丰.糖基化终产物对糖尿病微血管病变的作用[J].中国微循环,2004,8(3):195-196. 被引量:15
  • 2荆爱玉,张春虹,谢璇,王俊宏.老年2型糖尿病血浆同型半胱氨酸与糖尿病微血管病变关系研究[J].实用老年医学,2007,21(4):246-248. 被引量:5
  • 3唐霓,唐显玲.糖尿病血液流变性改变与微血管病变关系的研究进展[J].微循环学杂志,2007,17(3):60-61. 被引量:23
  • 4Wendt T, Tanji N, Guo J, eta 1.Glucose, glycation, and RAGE :implications for amplification of cellular dysfunction in diabetic nephropathy[J]. J Am Soc Nephrol. 2003,14(5) : 1383.
  • 5Yamamoto Y, Doi T, Kato I, et al. The role of AGE-RAGE system in the development of diabetic nephropathy in vivo[J]. International Congress Series, 2002, 12(12):45.
  • 6White KE. Bilous RW. Diabiopsies Study Group. Structural alterations to the podocyte are rela~ed to proteinuria in type 2 diabetic patients[J]. Nephrol Di.al Transplant, 2004,19(6):1437.
  • 7Pavenstdt H,Kriz W, Kretzler M, et al. Cell biology of the glomerular podocyte[J]. Physiol Rev, 2003, 83(1):253.
  • 8Doublier S, Salvidio G,Lupia E,et al.Nephriu expression is reduced in human diabetic nephropathy:evidence for a distinct role for glycated albumin and angiotensin 11 [J]. Diabeties, 2003,52(4): 1023.
  • 9Saleem MA, O' Hare M J, Reiser J, et al. A conditionally immortalized human podoeyte cell line demonstrating nephrin and podocin expression [J]. J Am Soc Nephrol, 2002, 13( 3 ): 630.
  • 10Koop K, Eikmans M, Baelde HJ, et al. Expression of podoeyte-as-sociated molecules in acquired human kidney doseases[J]. J Am Soc Nephrol, 2003,14 ( 8 ) :2063.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部